Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.

Journal of medical virology - 1 May 2005

de Mendoza Carmen, Martín-Carbonero Luz, Gallego Oscar, Corral Angélica, González-Lahoz Juan, Soriano Vincent

Abstract excerpt

Transmission of drug-resistant viruses has been shown to be associated with lower virus replication capacity and higher CD4+ cell counts in recent human immunodeficiency virus (HIV) seroconvertors. The impact of drug resistance mutations on CD4 cell counts in chronically HIV-infected patients has not been examined. A total of 825 patients whose plasma specimens were submitted to a reference laboratory for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chronic Disease

Share to Multivariate Analysis

Share to RNA-Directed DNA Polymerase

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 15778973
DOI: 10.1002/jmv.20316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.PMID 15778973Read ↗

Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.Semantic proximity Read ↗

Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.Semantic proximity Read ↗

Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.Semantic proximity Read ↗

Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009.Semantic proximity Read ↗

Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.Semantic proximity Read ↗

Analysis of HIV-1 drug-resistant variants in plasma and peripheral blood mononuclear cells from untreated individuals: implications for clinical management.Semantic proximity Read ↗

The use of human immunodeficiency virus resistance tests in clinical practice.Semantic proximity Read ↗

Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy.Semantic proximity Read ↗

Effects of drug resistance on viral load in patients failing antiretroviral therapy.Semantic proximity Read ↗

INVESTIGATION OF ANTIRETROVIRAL THERAPY (ART) USE AND DRUG RESISTANCE CHARACTERISTICS IN HIV-POSITIVE PATIENTSSemantic proximity Read ↗

Correlation of HIV-1 drug resistant mutations and virologic failure.Semantic proximity Read ↗

Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.